Andrew Jackson/LinkedIn
Jun 13, 2026, 14:48
Andrew Jackson: Personalized Approaches to Catheter-Related Thrombosis Prevention
Andrew Jackson, Owner of IVTEAM LTD, shared a post on LinkedIn:
“Catheter-related thrombosis prevention – full text.
‘The use of anticoagulant drugs (both prophylactic and therapeutic), antiplatelet therapy, and PICC use significantly lowered the risk of CRT.
The findings support personalized prevention strategies and underscore the need for a well-designed randomized controlled trial to validate these findings’ La Cava et al (2026).”
Stay updated with Hemostasis Today.
-
Jun 13, 2026, 14:45Ghazaleh Bankefors: Reconnecting Across Borders and Decades at EHA 2026
-
Jun 13, 2026, 14:41Tom Langenaeken: Targeting Factor XI in Mechanical Heart Valve Thrombosis
-
Jun 13, 2026, 14:36Heghine Khachatryan: Pregnancy, Thrombosis, and Aspirin – Who Really Needs Prophylaxis?
-
Jun 13, 2026, 14:24Thomas Stauch: ITP Therapeutics Enter a New Era of Targeted Treatment
-
Jun 13, 2026, 14:07Long-Term Outcomes and Future Directions in Hemophilia Gene Therapy: Insights from EHA 2026
-
Jun 13, 2026, 14:01Heghine Khachatryan: What EHA 2026 Reveals About the Future of Aplastic Anemia Treatment
-
Jun 13, 2026, 12:50Cornelia Englisch: Insights Into Clonal Hematopoiesis and Thrombosis Risk at EHA 2026
-
Jun 13, 2026, 11:18Mavis Agnes Kisakye: Transforming Lives Through the WFH Humanitarian Aid Program in Uganda
-
Jun 13, 2026, 10:48Humberto Cruz Esparra: Stroke Recovery Is More Than Regaining Function